Discrimination of ischemic and hemorrhagic strokes using a multiplexed, mass spectrometry-based assay for serum apolipoproteins coupled to multi-marker ROC algorithm

Apolipoprotein CIII Links Dyslipidemia with Atherosclerosis

(2011) Akio Kawakami et al.   Journal of Atherosclerosis and Thrombosis

Evaluation of absolute peptide quantitation strategies using selected reaction monitoring

(2011) James Campbell et al.   PROTEOMICS

The challenge of mixed cerebrovascular disease

(2010) Mark Fisher   Annals of the New York Academy of Sciences

Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype

(2010) Chunyu Zheng et al.   CIRCULATION

Executive Summary: Heart Disease and Stroke Statistics—2010 Update

(2010) et al.   CIRCULATION

HDL in humans with cardiovascular disease exhibits a proteomic signature

(2010) Tomáš Vaisar et al.   CLINICA CHIMICA ACTA

Simultaneous Quantification of Apolipoprotein A-I and Apolipoprotein B by Liquid-Chromatography-Multiple- Reaction-Monitoring Mass Spectrometry

(2010) S. A. Agger et al.   CLINICAL CHEMISTRY

Genetic aspects of ischemic stroke: coagulation, homocysteine, and lipoprotein metabolism as potential risk factors

(2010) Sanja Stankovic et al.   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

Discriminative Capacity of Biomarkers for Acute Stroke in the Emergency Department

(2010) Seth W. Glickman et al.   JOURNAL OF EMERGENCY MEDICINE

Platform for Establishing Interlaboratory Reproducibility of Selected Reaction Monitoring-Based Mass Spectrometry Peptide Assays

(2010) A. Prakash et al.   JOURNAL OF PROTEOME RESEARCH

Mass Spectrometric Discovery and Selective Reaction Monitoring (SRM) of Putative Protein Biomarker Candidates in First Trimester Trisomy 21 Maternal Serum

(2010) Mary F Lopez et al.   JOURNAL OF PROTEOME RESEARCH

Quantitative analysis of intact apolipoproteins in human HDL by top-down differential mass spectrometry

(2010) Matthew T. Mazur et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Proteomics of Apolipoproteins and Associated Proteins From Plasma High-Density Lipoproteins

(2009) Pia Davidsson et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review

(2009) Marianne Benn   ATHEROSCLEROSIS

Apolipoprotein Measurements: Is More Widespread Use Clinically Indicated?

(2009) Michael H. Davidson   CLINICAL CARDIOLOGY

Full-Length Characterization of Proteins in Human Populations

(2009) C. R. Borges et al.   CLINICAL CHEMISTRY

Selected Reaction Monitoring-Mass Spectrometric Immunoassay Responsive to Parathyroid Hormone and Related Variants

(2009) M. F. Lopez et al.   CLINICAL CHEMISTRY

Lipoprotein components and risk of congestive heart failure in 84 740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)

(2009) Ingar Holme et al.   EUROPEAN JOURNAL OF HEART FAILURE

Multiple Reaction Monitoring-based, Multiplexed, Absolute Quantitation of 45 Proteins in Human Plasma

(2009) Michael A. Kuzyk et al.   MOLECULAR & CELLULAR PROTEOMICS

Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma

(2009) Terri A Addona et al.   NATURE BIOTECHNOLOGY

Invited Article: Searching for oracles?: Blood biomarkers in acute stroke

(2009) C. Foerch et al.   NEUROLOGY

Apolipoprotein C-III: understanding an emerging cardiovascular risk factor

(2008) Esther M. M. Ooi et al.   CLINICAL SCIENCE

An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?

(2008) D. C. Chan et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Performance characteristics of an FT MS-based workflow for label-free differential MS analysis of human plasma: standards, reproducibility, targeted feature investigation, and application to a model of controlled myocardial infarction

(2008) Jennifer Sutton et al.   Proteomics Clinical Applications

Clinical Usefulness of a Biomarker-Based Diagnostic Test for Acute Stroke

(2008) Daniel T. Laskowitz et al.   STROKE